Kun-Ju Lin1,2, Ing-Tsung Hsiao3,4, Jung-Lung Hsu5,6, Chin-Chang Huang7, Kuo-Lun Huang7, Chia-Ju Hsieh3,4, Shiaw-Pyng Wey3,4, Tzu-Chen Yen3,4. 1. Department of Nuclear Medicine and Molecular Imaging Center, Linkou Chang Gung Memorial Hospital and University, 5. Fu-Hsing Street, Kuei Shan Hsiang, Taoyuan, Taiwan. lin4857@adm.cgmh.org.tw. 2. Department of Medical Imaging and Radiological Sciences and Healthy Aging Research Center, Chang Gung University, Taoyuan, Taiwan. lin4857@adm.cgmh.org.tw. 3. Department of Nuclear Medicine and Molecular Imaging Center, Linkou Chang Gung Memorial Hospital and University, 5. Fu-Hsing Street, Kuei Shan Hsiang, Taoyuan, Taiwan. 4. Department of Medical Imaging and Radiological Sciences and Healthy Aging Research Center, Chang Gung University, Taoyuan, Taiwan. 5. Section of Dementia and Cognitive Impairment, Department of Neurology, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan. 6. Graduate Institute of Humanities in Medicine, Taipei Medical University, Taipei, Taiwan. 7. Department of Neurology, Linkou Chang Gung Memorial Hospital and University, Taoyuan, Taiwan.
Abstract
PURPOSE: We investigated dual-phase (18)F-florbetapir (AV-45/Amyvid) PET imaging for the concomitant detection of brain perfusion deficits and beta-amyloid deposition in patients with Alzheimer's disease (AD) and amnestic mild cognitive impairment (MCI), and in cognitively healthy controls (HCs). METHODS: A total of 82 subjects (24 AD patients, 44 MCI patients and 14 HCs) underwent both dual-phase (18)F-AV-45 PET and MRI imaging. Dual-phase dynamic PET imaging consisted of (1) five 1-min scans obtained 1 - 6 min after tracer injection (perfusion (18)F-AV-45 imaging, pAV-45), and (2) ten 1-min scans obtained 50 - 60 min after tracer injection (amyloid (18)F-AV-45 imaging). Amyloid-negative MCI/AD patients were excluded. Volume of interest analysis and statistical parametric mapping of pAV-45 and (18)F-AV-45 images were performed to investigate the perfusion deficits and the beta-amyloid burden in the three study groups. The associations between Mini-Mental State Examination (MMSE) scores and global perfusion deficits and amyloid deposition were investigated with linear and segmental linear correlation analyses. RESULTS: HCs generally had normal pAV-45 findings, whereas perfusion deficits were evident in the hippocampus, and temporal, parietal and middle frontal cortices in both MCI and AD patients. The motor-sensory cortex was relatively preserved. MMSE scores in the entire study cohort were significantly associated with the degree of perfusion impairment as assessed by pAV-45 imaging (r = 0.5156, P < 0.0001). (18)F-AV-45 uptake was significantly higher in AD patients than in the two other study groups. However, the correlation between MMSE scores and (18)F-AV-45 uptake in MCI patients was more of a binary phenomenon and began in MCI patients with MMSE score 23.14 when (18)F-AV-45 uptake was higher and MMSE score lower than in patients with early MCI. Amyloid deposition started in the precuneus and the frontal and temporal regions in early MCI, ultimately reaching the maximum burden in advanced MCI. CONCLUSION: Our results indicate that brain perfusion deficits and beta-amyloid deposition in AD follow different trajectories that can be successfully traced using dual-phase (18)F-AV-45 PET imaging.
PURPOSE: We investigated dual-phase (18)F-florbetapir (AV-45/Amyvid) PET imaging for the concomitant detection of brain perfusion deficits and beta-amyloid deposition in patients with Alzheimer's disease (AD) and amnestic mild cognitive impairment (MCI), and in cognitively healthy controls (HCs). METHODS: A total of 82 subjects (24 ADpatients, 44 MCI patients and 14 HCs) underwent both dual-phase (18)F-AV-45 PET and MRI imaging. Dual-phase dynamic PET imaging consisted of (1) five 1-min scans obtained 1 - 6 min after tracer injection (perfusion (18)F-AV-45 imaging, pAV-45), and (2) ten 1-min scans obtained 50 - 60 min after tracer injection (amyloid (18)F-AV-45 imaging). Amyloid-negative MCI/ADpatients were excluded. Volume of interest analysis and statistical parametric mapping of pAV-45 and (18)F-AV-45 images were performed to investigate the perfusion deficits and the beta-amyloid burden in the three study groups. The associations between Mini-Mental State Examination (MMSE) scores and global perfusion deficits and amyloid deposition were investigated with linear and segmental linear correlation analyses. RESULTS: HCs generally had normal pAV-45 findings, whereas perfusion deficits were evident in the hippocampus, and temporal, parietal and middle frontal cortices in both MCI and ADpatients. The motor-sensory cortex was relatively preserved. MMSE scores in the entire study cohort were significantly associated with the degree of perfusion impairment as assessed by pAV-45 imaging (r = 0.5156, P < 0.0001). (18)F-AV-45 uptake was significantly higher in ADpatients than in the two other study groups. However, the correlation between MMSE scores and (18)F-AV-45 uptake in MCI patients was more of a binary phenomenon and began in MCI patients with MMSE score 23.14 when (18)F-AV-45 uptake was higher and MMSE score lower than in patients with early MCI. Amyloid deposition started in the precuneus and the frontal and temporal regions in early MCI, ultimately reaching the maximum burden in advanced MCI. CONCLUSION: Our results indicate that brain perfusion deficits and beta-amyloid deposition in AD follow different trajectories that can be successfully traced using dual-phase (18)F-AV-45 PET imaging.
Authors: Erik S Musiek; Yufen Chen; Marc Korczykowski; Babak Saboury; Patricia M Martinez; Janet S Reddin; Abass Alavi; Daniel Y Kimberg; David A Wolk; Per Julin; Andrew B Newberg; Steven E Arnold; John A Detre Journal: Alzheimers Dement Date: 2011-10-21 Impact factor: 21.566
Authors: Philipp T Meyer; Sabine Hellwig; Florian Amtage; Christof Rottenburger; Ursula Sahm; Peter Reuland; Wolfgang A Weber; Michael Hüll Journal: J Nucl Med Date: 2011-02-14 Impact factor: 10.057
Authors: Soichiro Shimizu; Yu Zhang; Joel Laxamana; Bruce L Miller; Joel H Kramer; Michael W Weiner; Norbert Schuff Journal: Brain Imaging Behav Date: 2010-03 Impact factor: 3.978
Authors: Natalie Nelissen; Koen Van Laere; Lennart Thurfjell; Rikard Owenius; Mathieu Vandenbulcke; Michel Koole; Guy Bormans; David J Brooks; Rik Vandenberghe Journal: J Nucl Med Date: 2009-07-17 Impact factor: 10.057
Authors: Christian Habeck; Shannon Risacher; Grace J Lee; M Maria Glymour; Elizabeth Mormino; Shubhabrata Mukherjee; Sungeun Kim; Kwangsik Nho; Charles DeCarli; Andrew J Saykin; Paul K Crane Journal: Brain Imaging Behav Date: 2012-12 Impact factor: 3.978
Authors: Dawn C Matthews; Ana S Lukic; Randolph D Andrews; Miles N Wernick; Stephen C Strother; Mark E Schmidt Journal: Alzheimers Dement (N Y) Date: 2022-07-08
Authors: Nelly Joseph-Mathurin; Yi Su; Tyler M Blazey; Mateusz Jasielec; Andrei Vlassenko; Karl Friedrichsen; Brian A Gordon; Russ C Hornbeck; Lisa Cash; Beau M Ances; Thomas Veale; David M Cash; Adam M Brickman; Virginia Buckles; Nigel J Cairns; Carlos Cruchaga; Alison Goate; Clifford R Jack; Celeste Karch; William Klunk; Robert A Koeppe; Daniel S Marcus; Richard Mayeux; Eric McDade; James M Noble; John Ringman; Andrew J Saykin; Paul M Thompson; Chengjie Xiong; John C Morris; Randall J Bateman; Tammie L S Benzinger Journal: Alzheimers Dement (Amst) Date: 2018-09-27
Authors: Paul C Donaghy; Michael J Firbank; Alan J Thomas; Jim Lloyd; George Petrides; Nicola Barnett; Kirsty Olsen; John T O'Brien Journal: Mov Disord Date: 2018-04-19 Impact factor: 10.338